Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi ORCID identifier: https://orcid.org/0000-0002-0908-3741 |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Pacemaker; Anticoagulation; Bleeding;
As a clinical cardiologist with a specific research interest in atrial fibrillation (AF) and long-term complications after percutaneous and surgical procedures, I have established a research group, which includes 10 PhD students at present. From a clinical point of view, my specific focus is AF patients undergoing cardiac procedures.
PI leads CAREFIB Consortium, which aims to reduce the burden of atrial fibrillation and its adverse outcome stroke in patients undergoing cardiac procedures. This consortium is divided into three major studies: a retrospective epidemiological CAREAVR study; a prospective CAREBANK biobank and a prospective LAA-CLOSURE trial.
Cardiology, ECG, Echocardiography, Atrial fibrillation, Anticoagulation
- Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography (2007)
- Ultrasound in Medicine and Biology
(A1 Refereed original research article in a scientific journal)



